Jafron Biomedical Co.,Ltd. (SHE:300529)
23.28
-0.57 (-2.39%)
Aug 14, 2025, 2:45 PM CST
Jafron Biomedical Revenue
Jafron Biomedical had revenue of 547.84M CNY in the quarter ending March 31, 2025, a decrease of -26.40%. This brings the company's revenue in the last twelve months to 2.48B, up 18.47% year-over-year. In the year 2024, Jafron Biomedical had annual revenue of 2.68B with 39.27% growth.
Revenue (ttm)
2.48B
Revenue Growth
+18.47%
P/S Ratio
7.23
Revenue / Employee
886.96K
Employees
2,797
Market Cap
17.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.68B | 754.97M | 39.27% |
Dec 31, 2023 | 1.92B | -569.09M | -22.84% |
Jan 1, 2023 | 2.49B | -184.02M | -6.88% |
Jan 1, 2022 | 2.68B | 724.67M | 37.15% |
Dec 31, 2020 | 1.95B | 518.96M | 36.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
WuXi AppTec | 41.48B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |